# OnCo record nct02960022 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct02960022/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct02960022", "NCT02960022" ;
  schema:name "A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study"@en ;
  schema:description "A phase 2 trial of Enzalutamide, Abiraterone acetate, Prednisone in prostate cancer, run by Astellas Pharma Global Development, Inc., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct02960022/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02960022> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2016-12-22" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/androgen-deprivation/> ;
  onco:drugs <https://onco.cc/drugs/enzalutamide/>, <https://onco.cc/drugs/abiraterone/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/goserelin/> ;
  onco:companies <https://onco.cc/companies/astellas/> .